Recent publications on Cancer

Sheridan L, Pocobelli G, Anderson M, Li CI, Kruse GR, Tiro JA, Kamineni A Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019 2025 Mar;36(3):275-284. doi: 10.1007/s10552-024-01937-6. Epub 2024-11-13. PubMed

Franklin IR, Gambatese R, Duggan MC, Green BB, Nocon RS, Coronado GD, Hahn EE, Honda SA, Koplan K, Levin TR, Steiner CA, Ngo-Metzger Q Colorectal Cancer Screening and Social Needs 2025 Feb 20;37(5):868-887. doi: 10.3122/jabfm.2023.230497R1. Epub 2025-01-02. PubMed

Chubak J, Ichikawa LE, Merchant SA, Dalmat RR, Ziebell RA, Jensen CD, Lee JK, Corley DA, Ghai NR, Green BB, Skinner CS, Schottinger JE, Breslau ES, Levin TR Incidence of serious complications following screening colonoscopy in adults aged 76 to 85 years old 2025 Feb 6;34(2):281-289. doi: 10.1158/1055-9965.EPI-24-0551. Epub 2024-11-25. PubMed

Lange JM, Gard CC, O'Meara ES, Miglioretti DL, Etzioni R Breast density and risk of breast cancer: masking and detection bias 2025 Feb 5;194(2):441-448. doi: 10.1093/aje/kwae245. Epub 2024-08-03. PubMed

Jones SW, Yi JC, Henrikson NB, Panattoni L, Shankaran V. Development of item banks to assess financial hardship in cancer survivors using item response theory. Front Cancer Control. 2025 Feb 4. Vol. 3. https://doi.org/10.3389/fcacs.2025.1452970. PubMed

Wang P, O'Connell K, Bhimani J, Blinder V, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Kushi LH, Aiello Bowles EJ, Kantor ED Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study 2025 Feb;9:e2400231. doi: 10.1200/CCI-24-00231. Epub 2025-02-14. PubMed

Lawson MB, Zhu W, Miglioretti DL, Onega T, Henderson LM, Rauscher GH, Kerlikowske K, Sprague BL, Bowles EJA, O'Meara ES, Tosteson ANA, diFlorio-Alexander RM, Hubbard RA, Lee JM, Lee CI Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography 2025 Feb;314(2):e241673. doi: 10.1148/radiol.241673. PubMed

Murphy NR, Crothers K, Snidarich M, Budak JZ, Brown MC, Weiner BJ, Giustini N, Caverly T, Durette K, DeCell K, Triplette M A tailored decision aid improves understanding of lung cancer screening in people with HIV 2025 Jan;167(1):259-269. doi: 10.1016/j.chest.2024.07.147. Epub 2024-07-29. PubMed

Figueroa Gray M, Randall S, Banegas M, Ryan GW, Henrikson NB Personal legacy and treatment choices for serious illness: a scoping review 2024 Dec 19;14(e3):e2302-e2315. doi: 10.1136/spcare-2023-004439. Epub 2024-01-24. PubMed

Issaka RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, Clark CR, Del Vecchio NJ, Kamineni A, Neslund-Dudas C, Chubak J, Corley DA, Haas JS, Honda SA, Li CI, Winer RL, Pruitt SL Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems 2024 Dec 15;130(24):4287-4297. doi: 10.1002/cncr.35514. Epub 2024-08-09. PubMed

Harlass M, Dalmat RR, Chubak J, van den Puttelaar R, Udaltsova N, Corley DA, Jensen CD, Collier N, Ozik J, Lansdorp-Vogelaar I, Meester RGS Optimal Stopping Ages for Colorectal Cancer Screening 2024 Dec 2;7(12):e2451715. doi: 10.1001/jamanetworkopen.2024.51715. Epub 2024-12-02. PubMed

Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results 2024 Dec;39(16):3217-3224. doi: 10.1007/s11606-024-08943-z. Epub 2024-07-25. PubMed

Levin TR, Jensen CD, Udaltsova N, Burnett-Hartman AA, Kamineni A, Chao CR, Schottinger JE, Ghai NR, Pocobelli G, White LL, Oliver M, Chowdhry H, Hixon BP, Badalov JM, Goldberg SR, Bradford SC, Quesenberry CP, Lee JK Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational Study 2024 Dec;177(12):1621-1629. doi: 10.7326/M24-0743. Epub 2024-10-22. PubMed

Bowles EJA, Ramin C, Vo JB, Feigelson HS, Gander JC, Veiga LHS, Bodelon C, Curtis RE, Brandt C, de Gonzalez AB, Gierach GL Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018 2024 Dec;208(3):577-587. doi: 10.1007/s10549-024-07453-0. Epub 2024-08-16. PubMed

Fernandes-Taylor S, Bowles EJA, Venkatesh M, Doud R, Krebsbach C, Arroyo N, Hanlon B, Chen AY, Davies L, Francis DO Differential Ultrasound Rates Mirror Sex Disparities in Thyroid Cancer 2024 Dec;34(12):1531-1539. doi: 10.1089/thy.2024.0344. Epub 2024-11-28. PubMed

Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study 2024 Dec;39(16):3205-3216. doi: 10.1007/s11606-024-08764-0. Epub 2024-05-21. PubMed

Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley MJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer 2024 Nov;155(9):1577-1592. doi: 10.1002/ijc.35053. Epub 2024-07-06. PubMed

Lee JM, Ichikawa LE, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli KJ, Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL Relative timing of mammography and MRI for breast cancer screening: Impact on performance evaluation 2024 Nov;21(11):1722-1732. doi: 10.1016/j.jacr.2024.06.020. Epub 2024-07-03. PubMed

Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system 2024 Nov;208(2):405-414. doi: 10.1007/s10549-024-07433-4. Epub 2024-08-16. PubMed

Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer 2024 Oct 2;33(10):1286-1297. doi: 10.1158/1055-9965.EPI-24-0360. Epub 2024-07-25. PubMed